✦ LIBER ✦

Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression

✍ Scribed by Dan Luedke; Timothy T. McLaughlin; Carlos Daughaday; Susan Luedke; Bruce Harrison; Garry Reed; Orlando Martello

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 361 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850201)55:3<542::aid-cncr2820550312>3.0.co;2-9

No coin nor oath required. For personal study only.

✦ Synopsis

A patient receiving mitomycin and vindesine chemotherapy for lung cancer developed abrupt onset of shortness of breath following vindesine administration. Pulmonary function tests both before and after rechallenging him with vindesine showed an acute obstructive pattern, which resolved with bronchodilator therapy; persisting lung damage was evident by arterial blood gas analysis. A record review of the 126 patients placed on the same chemotherapy regimen uncovered an additional 6 patients with possible lung toxicity. These seven patients (5.5%) had a variable clinical picture, from acute, reversible shortness of breath temporally related to vindesine administration to a progressive, fatal interstitial infiltrate. Physicians administering the combination of mitomycin and a vinca alkaloid should be aware of potential lung toxicity with variable clinical expression and be prepared to take appropriate action should they encounter it.

📜 SIMILAR VOLUMES

A case of pulmonary toxicity associated

A case of pulmonary toxicity associated with G-CSF and doxorubicin administration

✍ C. F. Eisenbeis; D. Winn; S. Poelman; C. V. Polsky; J. H. Rubenstein; O. I. Olop 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 95 KB

Pulmonary hypertension associated with s

Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes

✍ Laura M. De Castro; Jude C. Jonassaint; Felicia L. Graham; Allison Ashley-Koch; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

Pulmonary arterial hypertension and left

Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: Clinical characteristics and association with soluble adhesion molecule expression

✍ Elizabeth S. Klings; Demedrick Anton Bland; Dara Rosenman; Stephanie Princeton; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

## Abstract Pulmonary hypertension (PH), a risk factor for mortality in sickle cell disease (SCD), has pathologic features of both pulmonary arterial hypertension (PAH) and PH related to left‐sided heart disease (LHD) suggesting a link between these two entities. We hypothesized that both are chara

Osteopontin C mRNA expression is associa

Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer

✍ Neill Patani; Wen Jiang; Kefah Mokbel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 1 views

Pharmacokinetics of ecteinascidin 743 ad

Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity

✍ Thomas A. Puchalski; David P. Ryan; Rocio Garcia-Carbonero; George D. Demetri; L 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 155 KB

Therapy of disseminated malignant melano

Therapy of disseminated malignant melanoma with recombinant α 2b-interferon and piroxicam: Clinical results with a report of an unusual response-associated feature (Vitiligo) and unusual toxicity (diffuse pulmonary interstitial fibrosis)

✍ Harris, Jules ;Bines, Steven ;Das Gupta, Tapas 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

## Abstract Fifteen patients with disseminated malignant melanoma were treated with recombinant a 2b‐interferon (20 mU/m^2^ intravenously 5 days per week for 4 weeks and then 10 mU/m^2^ subcutaneously tiw) and piroxicam (10 mg a day orally for 10 days prior to beginning interferon and daily thereaf